A potentially ground-breaking treatment for nerve damage caused by diabetes
has shown promising results in preclinical and early patient trials. A
University of Manchester team has discovered that injection of a novel
therapeutic that works by stimulating a person's genes may prevent nerve
damage - primarily to the hands and feet - caused by the disease.
The positive preclinical results - reported in the journal "Diabetes" are
further evidence that the research could lead to a new treatment for diabetic
nerve damage or 'neuropathy'; initial-stage clinical trials on patients in
the United States have also been encouraging. Lead researcher Professor David
Tomlinson said the study has massive potential for managing the condition and
preventing thousands of foot amputations each year.
Learn more>>
http://main.diabetes.org/site/R?i=fbRIaGhwGx0N1LCfx03LQg
has shown promising results in preclinical and early patient trials. A
University of Manchester team has discovered that injection of a novel
therapeutic that works by stimulating a person's genes may prevent nerve
damage - primarily to the hands and feet - caused by the disease.
The positive preclinical results - reported in the journal "Diabetes" are
further evidence that the research could lead to a new treatment for diabetic
nerve damage or 'neuropathy'; initial-stage clinical trials on patients in
the United States have also been encouraging. Lead researcher Professor David
Tomlinson said the study has massive potential for managing the condition and
preventing thousands of foot amputations each year.
Learn more>>
http://main.diabetes.org/site/R?i=fbRIaGhwGx0N1LCfx03LQg
No comments:
Post a Comment